Brief: Advaxis Announces Initiation Of Phase 1 Clinical Trial Of ADXS-504 For Treatment Of Early Prostate Cancer
15/07/2021 13:41
July 15 (Reuters) - Advaxis Inc ADXS.O :
* ADVAXIS ANNOUNCES INITIATION OF PHASE 1 CLINICAL TRIAL OF
ADXS-504 FOR THE TREATMENT OF EARLY PROSTATE CANCER
Source text for Eikon: ID:nGNXbnrNPg
Further company coverage: ADXS.O
(Reporting by Shreyasee Raj)
((Shreyasee.Raj@thomsonreuters.com;))
Recent news on Ayala Pharmaceuticals
See all newsBrief: Ayala Pharmaceuticals Completes Sale Of AL102 To Immunome
Immunome slides on $200 mln equity offering
Immunome edges up after $200 mln equity offering
Brief: Immunome To Acquire AL102 Phase 3 Asset for the Treatment of Desmoid Tumors From Ayala Pharmaceuticals
Brief: Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors